Patent Application
20110213467
1. Field of the Disclosure.
The present disclosure relates to methods and apparatuses for attaching tissue structures, including soft tissue structures and/or bone, to orthopaedic implants. More particularly, the present disclosure relates to methods and apparatuses for attaching soft tissue structures and/or bone to an orthopaedic implant using woven ingrowth material on the implant.
2. Description of the Related Art.
Orthopaedic implants are commonly used to replace at least a portion of a patient's joint in order to restore the use of the joint, or to increase the use of the joint, following deterioration due to aging or illness, injury due to trauma, or disease.
The present disclosure provides methods and apparatuses for attaching soft tissue and/or bone to orthopaedic implants. The orthopaedic implants are provided with a woven ingrowth material to facilitate attachment of soft tissue and/or bone thereto. In one embodiment, the woven ingrowth material is formed as a patch or region of woven material attached to the implant. In another embodiment, a sleeve formed of woven ingrowth material encompasses the majority of the implant.
In one form thereof, the present disclosure provides an orthopaedic implant assembly for positioning in a bone adjacent a tissue structure. The orthopaedic implant assembly includes an orthopaedic implant suitable for replacing at least a portion of the bone, a woven material having a first, body portion that is fixedly secured to said orthopaedic implant to prevent relative movement between said body portion of said woven material and said orthopedic implant, and a second, extension portion that extends freely away from said orthopaedic implant, and a fastener sized for securement into said woven material to operably secure the tissue structure to said orthopaedic implant. When the orthopaedic implant is positioned adjacent the tissue structure, the woven material is accessible outside the bone and the tissue structure is securable to the orthopaedic implant via attachment of the fastener into the woven material.
In another form thereof, the present disclosure provides an orthopaedic implant assembly for positioning in a tibia adjacent a tissue structure. The orthopaedic implant assembly includes a tibial implant suitable for replacing at least a portion of the tibia, a woven material, and a fastener. The tibial implant includes a body having a proximal end, a distal end opposite the proximal end, an anterior surface, a posterior surface opposite the anterior surface, a medial surface, and a lateral surface opposite the medial surface, and a tray coupled to the proximal end of the body. The woven material has a first, body portion that is fixedly secured to the tibial implant to prevent relative movement between the body portion of the woven material and the tibial implant, and a second, extension portion that extends freely away from the tibial implant. The fastener is sized for securement into said woven material to operably secure the tissue structure to said tibial implant. When the tibial implant is positioned adjacent the tissue structure, the woven material is accessible outside the tibia and the tissue structure is securable to the tibial implant via attachment of the fastener into the woven material.
In yet another form thereof, the present disclosure provides a method for attaching a tissue structure to an orthopaedic implant, the orthopaedic implant implantable in a bone. The method includes the steps of: providing an orthopaedic implant with a woven material secured thereto, the woven material having a first, body portion that is fixedly secured to the orthopaedic implant to prevent relative movement between the body portion of the woven material and the orthopedic implant, and a second, extension portion that extends freely away from the orthopaedic implant; positioning the orthopaedic implant in the bone such that the woven material is accessible outside the bone; and securing the tissue structure to the woven material by connecting a fastener directly into the woven material.
The above-mentioned and other features of the disclosure, and the manner of attaining them, will become more apparent and will be better understood by reference to the following description of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate embodiments of the disclosure and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
Referring now to
Body 32 may be formed from relatively light-weight material, such as titanium, a cobalt chromium alloy, or other suitable biocompatible material, for example, thereby making it easier for the patient to lift and extend the knee joint, particularly in procedures which require extensive removal of muscle proximate the knee joint. In one embodiment, tibial plate 34 may be formed as a modular component of proximal tibial implant 30 to provide more interoperative options. In an exemplary embodiment, tibial plate 34 is formed as a wear-resistant tibial plate to minimize debris from articulation with another component (not shown) of the knee joint. Mating structure 36 may be formed complementary to a meniscal component (not shown) of the knee joint to provide either a mobile or a non-mobile bearing connection between proximal tibial implant 30 and the meniscal component. Proximal tibial implant 30 may also include rotational adjustment tabs 38 at distal end 40 to allow for in vivo rotational adjustment of proximal tibial implant 30 relative to another implant or to the remaining structure of the tibia. Rotational adjustment tabs 38 may generally extend distally from body 32 along a lateral and/or a medial side of implant 30. A plurality of tabs 38 or, alternatively, a single tab 38 may be utilized.
In an exemplary embodiment, proximal tibial implant 30 also includes at least one bone and/or soft tissue attachment region 44. Attachment region 44 may be positioned on an anterior surface of proximal tibial implant 30 and may be integrally formed with proximal tibial implant 30. In one embodiment, attachment region 44 is formed as a modular component of proximal tibial implant 30. Attachment region 44 may be positioned in a recess provided on the anterior surface of proximal tibial implant 30. Attachment region 44 may generally have a relatively thin thickness, e.g., as low as approximately 1 mm to as high as approximately 5 mm, such as to define a relatively slim profile such that attachment region 44 does not protrude from proximal tibial implant 30 and consequently potentially interfere with other anatomical structures. For example, in an exemplary embodiment, the anterior surface of attachment region 44 is substantially flush with anterior surface 47 of proximal tibial implant 30. Attachment region 44 provides a direct connection between bone and/or a soft tissue structure and proximal tibial implant 30. For example, a patella tendon, which joins a lower edge of a patella (not shown) of the knee joint with a tibial tubercle of a tibia, may be directly attached via mechanical and/or biological fixation to proximal tibial implant 30 after implantation of implant 30 via attachment region 44. Such fixation of the patella tendon to proximal tibial implant 30 enhances usability of the knee joint. For example, when a patient jumps into the air or allows the tibia to hang without any support, the fixation of the patella tendon to proximal tibial implant 30 prevents dislocation of the components of the prosthetic knee joint and facilitates normal functioning of the prosthetic knee joint after the jump or once the tibia is again supported. In one example, a rotating hinged knee includes a femoral component with a post extending through a meniscal component and into a tibial component. During a jump or when the tibia is unsupported, the patella tendon effectively prevents the post from extending too far from the tibial component and ensures that the post returns to proper engagement with the tibial component once normal functioning is resumed. As described further below, attachment region 44 may include at least one porous surface 45, such as a surface to facilitate ingrowth of bone and/or soft tissues.
In an exemplary embodiment, attachment region 44 is formed from a woven ingrowth material which facilitates ingrowth of soft tissue, bone, and/or other anatomical structures. For the purposes of this document, the term “woven” is defined as a material made or constructed by interlacing threads, strips, or pieces of material or other elements into a whole. Unlike an embroidered material that is formed by stitching and knotting threads into a pre-existing fabric, a woven material provides more control over the materials used the construct the final product and the mechanical properties of the final product. The woven ingrowth material may be formed from various materials, including, but not limited to, metals (i.e., titanium, tantalum, and cobalt chromium alloys), synthetic polymers (i.e., ultra-high molecular weight polyethylene (UHMWPE), polyether-ether-ketone (PEEK), and polyether-ketone (PEK)), bioresorbable fibers (i.e., PLA, PGA, PLLA, and PU), ceramics/glass (i.e., alumina, zirconia, and pyrolytic carbon), biological material (i.e., collagen, silk, and chitosan), and/or a composite of the same (i.e., carbon reinforced PEEK). The woven ingrowth material may be a flexible material to facilitate conforming attachment region 44 to a surface of an implant. In one exemplary embodiment, attachment region 44 may have a Young's modulus that is substantially similar to the Young's modulus of the surrounding bone, which may range from 12 to 20 GPa. The woven ingrowth material may have variable pore sizes such that the pore sizes may be denser near areas of contact with the implant to facilitate attachment of attachment region 44 to the implant. The woven ingrowth material may have a variable thickness and/or variable roughness or variation in pattern. The woven ingrowth material of attachment region 44 may be affixed to implant 30 via a fastener or an attachment mechanism such as, but not limited to, an adhesive such as a bioadhesive, diffusion bonding, a hook-and-loop fastener, a screw, a nail, a bolt, an integral fit, an interference fit, or attachment region 44 may be integrally formed with implant 30.
The woven ingrowth material may be configured to allow bone, soft tissue, and blood vessels to grow through attachment region 44, thereby reducing the potential of subcutaneous irritation and necrosis of the soft tissue structure. The woven ingrowth material may include tissue ingrowth enhancement properties, such as bone or tissue growth factors. The woven ingrowth material may also include other pharmacological and/or therapeutic agents. The woven ingrowth material may include seams therein to enhance the strength of the material and these seams may be created via laser welding, ultrasonic sealing, stitching, or other suitable methods. Examples of woven material which may be used with the present disclosure include the Artelon® CMC Spacer, available from Small Bone Innovations, Inc. of Morrisville, Pa., which has material properties including ultimate stress greater than 240 MPa and a porosity of approximately 90%; and the LARS™ Ligament Augmentation and Reconstruction System available from Corin Group PLC of Gloucestershire, United Kingdom.
In one embodiment, the woven ingrowth material may be a three-dimensional woven material as described in U.S. patent application Ser. No. 12/131,188 entitled “Implant Sensors” and/or U.S. patent application Ser. No. 12/640,655 entitled “In-Line Treatment of Yarn Prior to Creating a Fabric,” the disclosures of which are expressly incorporated by reference herein.
In another embodiment, the woven ingrowth material may be formed as a material having a cellular structure which resembles bone and approximates the physical and mechanical properties of bone, thereby enabling rapid and extensive bone and/or soft tissue infiltration and strong attachment of bone and/or soft tissue structures thereto. For example, the material may be a highly porous biomaterial having a porosity as low as 55, 65, or 75 percent and as high as 80, 85, or 90 percent. The woven material may be formed to mimic material produced using Trabecular Metal™ technology generally available from Zimmer, Inc., of Warsaw, Indiana. Trabecular Metal™ is a trademark of Zimmer Technology, Inc. Such a woven material may be formed with a similar process as that described by a chemical vapor deposition (“CVD”) process in the manner disclosed in detail in U.S. Pat. No. 5,282,861, the disclosure of which is expressly incorporated herein by reference. The woven material may include up to 75%-85% or more void space therein. The woven material may be made in a variety of densities in order to selectively tailor the structure for particular applications.
Implant 30 may also include extension region 46 formed of the same material and structure as attachment region 44 and having porous surface 45. In one exemplary embodiment, extension region 46 may have a Young's modulus that is substantially similar to the Young's modulus of the patella tendon, which may range from 1.3 to 2.2 GPa. In an exemplary embodiment, extension region 46 and attachment region 44 are formed as a unitary construct. In another embodiment, extension region 46 is attached to attachment region 44 via sutures, adhesive, or other suitable connection, either before or after affixation of attachment region 44 to implant 30.
In operation, a surgeon may attach a soft tissue structure, such as muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal tibial implant 30. The surgeon positions the soft tissue structure and/or bone in contact with the anterior surface of attachment region 44. At least one suture may be threaded through the woven ingrowth material of attachment region 44 at any desired location on attachment region 44 to attach the soft tissue structure and/or bone at least temporarily to implant 30. In contrast to sutures, a surgeon may also use surgical tape or surgical cables, for example. In one embodiment, the sutures may be biodegradable after a period of time in which the soft tissue structure and/or bone is permanently attached to proximal tibial implant 30 via ingrowth of the soft tissue structure and/or bone into attachment region 44. The ability to suture or fasten the soft tissue structure and/or bone directly to the woven ingrowth material and to suture therethrough eliminates the need for any apertures proximate attachment region 44 and extending through implant 30 for threading sutures therethrough. The potential risk of suture breakage is thereby substantially eliminated because the woven ingrowth material has no potential sharp edges. In this manner, the soft tissue structure and/or bone may be both biologically and mechanically affixed to proximal tibial implant 30. The close proximity of the suture attachments in attachment region 44 in relation to the soft tissue structure and/or bone further facilitates more direct contact between the soft tissue structure and/or bone and attachment region 44. Alternatively, the soft tissue structure and/or bone may be first attached to attachment region 44 and then attachment region 44 is attached to body 32, thereby providing potential for tensioning the soft tissue structure and/or bone prior to securement of attachment region 44 to body 32. In yet another embodiment, the soft tissue structure and/or bone is positioned between attachment region 44 and body 32 and then attachment region 44 is attached to body 32.
In an exemplary procedure, the surgeon may attach the soft tissue structure and/or bone to implant 30 via extension region 46, thereby providing an extension for attaching the soft tissue structure and/or bone. This may be required in situations in which the soft tissue structure and/or bone does not extend completely across implant 30 into contact with attachment region 44. The surgeon may use a similar procedure to affix the soft tissue structure and/or bone to extension region 46 as used to affix the same to attachment region 44, as described above.
Referring now to
In operation, a surgeon may attach a soft tissue structure, such as a muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal tibial implant 30A. The surgeon positions the soft tissue structure and/or bone in contact with the surface of attachment region 44 and secures the soft tissue structure and/or bone in a substantially identical manner as described above with respect to proximal tibial implant 30 (
Referring now to
In operation, a surgeon may attach a soft tissue structure, such as a muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal tibial implant 30B. The surgeon positions the soft tissue structure and/or bone in contact with the surface of attachment region 44 and secures the soft tissue structure and/or bone in a substantially identical manner as described above with respect to proximal tibial implant 30 (
Referring now to
In operation, a surgeon may attach a soft tissue structure, such as a muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal tibial implant 30C. The surgeon positions the soft tissue structure and/or bone in contact with the surface of attachment region 44 and secures the soft tissue structure and/or bone in a substantially identical manner as described above with respect to proximal tibial implant 30 (
Although shown in
Referring now to
In operation, a surgeon may attach a soft tissue structure, such as a muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal tibial implant 30D. The surgeon positions the soft tissue structure and/or bone in contact with the surface of attachment region 44 and secures the soft tissue structure in a substantially identical manner as described above with respect to proximal tibial implant 30 (
Referring now to
Proximal femoral implant 80 may include medial protrusion 86 and lateral protrusion 94. Medial protrusion 86 may include at least one attachment region 44. Medial protrusion 86 may buttress neck 84 and provide additional support to proximal femoral implant 80 when implanted into a hip joint. Lateral protrusion 94 may also include at least one attachment region 44. As shown in
In operation, a surgeon may attach a plurality of soft tissue structures, such as a muscle, a ligament, a capsule, and/or a tendon, for example, and/or bone to proximal femoral implant 80. The surgeon positions the soft tissue structure and/or bone in contact with the surface of any or all of attachment regions 44 and/or extension region 46 and secures the soft tissue structure and/or bone in a substantially identical manner as described above with respect to proximal tibial implant 30 (
Although not illustrated in
Although the methods and apparatuses described in this disclosure describe attachment of natural soft tissue structures to orthopaedic implants, the methods and apparatuses may also be used to secure artificial soft tissue structures to orthopaedic implants in substantially similar manners.
Furthermore, although the methods and apparatuses described in this disclosure describe attachment of soft tissue and/or bone structures to segmental orthopaedic implants, the methods and apparatuses may also be used to secure soft tissue and/or bone structures to any orthopaedic implant, such as hip implants, knee implants, elbow implants, shoulder implants such as a reverse shoulder implant, extremity implants, and trauma implants.
While this disclosure has been described as having exemplary designs, the present disclosure can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this disclosure pertains and which fall within the limits of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 12/690,295 entitled “Orthopaedic Implant with Woven Ingrowth Material,” filed Jan. 20, 2010, which claims priority from U.S. Provisional Patent Application No. 61/145,821, entitled “Orthopaedic Implant with Woven Ingrowth Material,” filed on Jan. 20, 2009, by the same inventors hereof, the disclosures of which are expressly incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 61145821 | Jan 2009 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12690295 | Jan 2010 | US |
| Child | 12873794 | US |
